Evaluating the ketogenic diet's effects on children with various conditions
Official title: Clinical and Nutritional Effectiveness and Impact on the Quality of Life of the Ketogenic Diet in Pediatric Patients With Neurological, Genetic or Metabolic Disorders: a Multicenter Prospective Observational Study
Run by Danone Nutricia SpA Società Benefit · NCT06309251 · Data updated 2026-11-12
This study is testing if the ketogenic diet can help children with conditions like epilepsy, autism, migraines, and brain tumors feel better and grow properly.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Danone Nutricia SpA Società Benefit Industry-sponsored |
| Locations | 3 sites (Milan, MI and 2 other locations) |
| Status | Recruiting |
| Started | March 1, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT06309251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pediatric patients under 18 years with drug-resistant epilepsy or other genetic, metabolic, or neurological conditions that require a ketogenic diet.
✕Probably not a fit
Patients with specific metabolic disorders affecting ketone metabolism or those with type 1 diabetes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the clinical and nutritional effectiveness of the ketogenic diet (KD) in pediatric patients with conditions such as drug-resistant epilepsy, autism spectrum disorder, chronic migraine, and brain tumors. It will explore whether KD supports adequate growth, improves clinical symptoms, and impacts the quality of life. Participants will be monitored according to standard clinical practices, focusing on both the effectiveness of KD and its nutritional implications. The study seeks to fill gaps in existing research regarding the broader applications of KD beyond epilepsy.
Why it matters
Potential benefit: If successful, this study could provide insights into how the ketogenic diet can enhance the quality of life and clinical outcomes for children with various neurological and metabolic conditions.
How similar studies have gone: Previous studies have shown promising results for the ketogenic diet in treating drug-resistant epilepsy, but this study aims to explore its effects in a broader range of conditions, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pediatric patients (aged \< 18 years) with drug-resistant epilepsy (fail to achieve (and maintain) seizure freedom with adequate trials of two or more antiseizure medications) or genetic, metabolic, neurological (congenital and acquired) diseases treated with ketogenic diet * Pediatric patients (aged \< 18 years) with metabolic, genetic or neurological (congenital and acquired) diseases (not necessarily associated with drug-resistant epilepsy) treated with ketogenic diet; this includes the new KD indications or the administration of KD in the ICU for status epilepticus. Exclusion Criteria: * Patients affected by beta-oxidation cycle disorders, systemic primary carnitine deficiency, primary dyslipidemia, pyruvate carboxylase deficiency, porphyria, mitochondrial disease, defects in ketone body metabolism (ketogenesis or ketolysis), defect in gluconeogenesis. * Children with type 1 diabetes * Parents (or caregivers) unable to guarantee adherence to the
Where it's running
-
ASST Fatebenefratelli Sacco (PO "V. Buzzi")
Milan, Mi, Italy Recruiting -
Fondazione "Istituto Neurologico Nazionale C. Mondino"
Pavia, Pv, Italy Recruiting -
Ospedale Pediatrico Bambino Gesù
Roma, Rm, Italy Recruiting
Study contacts
- Study coordinator: Antonella Diamanti, MD
- Email: antonella.diamanti@opbg.net
- Phone: +39 06 6859 2189
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensory Integration and Deep Pressure Therapy for Motor Coordination in Children with ASD
This study tests whether combining Sensory Integration Therapy with Deep Pressure Therapy can improve motor coordination and reduce repetitive behaviors in children aged 4–10 with autism.
-
Pupillometer screen to help identify autism in kids aged 2–4 during routine visits
A handheld pupillometer test is being tried to see if it can help identify autism in young children during regular pediatric visits.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Modified ketogenic diet for adults with drug-resistant epilepsy
This study tests whether a modified ketogenic diet can help adults with drug-resistant epilepsy see fewer seizures and feel better overall.
-
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.
-
Structured Sensory-Based Occupational Therapy for Children with Autism
This study tests a 12-week, 40-minute sensory-based occupational therapy program twice a week to see if it improves daily skills, sensory processing, movement, and eating in children aged 3-9 with autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.